Final global device documents available on GHTF (Global Harmonisation Task Force) website:
This article was originally published in Clinica
Final documents recently posted by Study Group 2 (SG2) of the Global Harmonisation Task Force on its website are as follows: manufacturers' trend reporting of adverse events; global medical device competent authority report; and medical device postmarket vigilance and surveillance: timing of adverse events reports. SG2 oversees documents concerning adverse event reporting, postmarket surveillance and vigilance. The reports are available at: www.ghtf.org/sg2/sg2-final.html
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.